{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":22,"n_cols":5,"rows_kept":22,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[16,2,16,3],[17,2,17,3],[20,2,20,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910171009903321"]
[null,null,"Titolo",null,"WHO Expert Committee on Drug Dependence : thirty-third report"]
[null,null,"Pubbl/distr/stampa",null,"Geneva, : World Health Organization, 2003"]
[null,null,"ISBN",null,"1-280-01137-8"]
[{"$nulls":4},"9786610011377"]
[{"$nulls":4},"0-585-49272-7"]
[{"$nulls":4},"92-4-068153-1"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (31 p.)"]
[null,null,"Collana",null,"WHO technical report series ; ; 915"]
[null,null,"Disciplina",null,"362.29"]
[null,null,"Soggetti",null,"Substance abuse"]
[{"$nulls":4},"Drug abuse"]
[{"$nulls":4},"Designer drugs"]
[{"$nulls":4},"Stereoisomers"]
[{"$nulls":4},"Ephedrine"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,"Nota di contenuto",null,"Contents; 1. Introduction; 2. Scheduling criteria; 3. Critical review of psychoactive substances; 4. Pre-review of psychoactive substances; 5. Terminology used in reporting abuse-related adverse drug reactions; 6. Other matters; Acknowledgements; References; Annex Terminology used in reporting abuse-related adverse drug reactions; References;"]
[null,null,null,"Sommario/riassunto","This report presents the recommendations of a WHO Expert Committee responsible for reviewing information on dependence-producing drugs to assess the need for their international control. The first part of the report contains a summary of the Committee's evaluations of seven substances (dronabinol, oripavine, buprenorphine, butorphanol, ketamine, khat and zopiclone). The report also discusses the substances that were pre-reviewed (gamma-hydroxybutyric acid and tramadol) and recommended gamma-hydroxybutyric acid for critical review at a future meeting. Two substances (gamma-butyrolactone and 1,4"]